We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Hold on to Voya Financial (VOYA) Now
Read MoreHide Full Article
Voya Financial Incorporation (VOYA - Free Report) is well-poised for growth backed by solid market presence and prudent capital deployment.
Estimates for Voya Financial have been revised upward over the past seven days, reflecting analysts’ confidence in the stock. The Zacks Consensus Estimate for 2020 earnings per share has moved up 0.2% in the said time frame. The company also beat estimates in two of the trailing four quarters by 0.86%, on average.
Shares of Voya Financial have gained 45.3% year to date, outperforming the industry’s rally of 25.9%.
Voya Financial’s core businesses segments Retirement, Investment Management and Employee Benefits are driving the company’s bottom line. These businesses fetch higher return and boast a solid market presence.
The company is committed to its objective of achieving improving EPS on the back of organic growth, cost savings and capital management. For 2019, the company expects normalized EPS growth to be around 10%.
Banking on operational excellence, the company deploys capital effectively to enhance shareholder value. Recently in August 2019, the company hiked dividend by 1400%. These endeavors make the stock an attractive pick for yield-seeking investors.
This Zacks Rank #3 (Hold) life insurer remains focused on reducing expenses. The company anticipates achieving run rate cost savings of at least $250 million by 2020 end.
The Zacks Consensus Estimate for 2019 is pegged at $4.97, indicating an improvement of 23% from the year-ago reported figure. The expected long-term earnings growth rate is pegged at 19.6% which betters the industry average of 11.4%. The stock also carries a favorable Value Score of B.
Stocks to Consider
Some better-ranked stocks from the same space are Donegal Group Incorporation (DGICA - Free Report) , American Equity Investment Life Holding Company (AEL - Free Report) and Primerica Incorporation (PRI - Free Report) . While Donegal Group Incorporation and American Equity Investment sport a Zacks Rank #1 (Strong Buy), Primerica carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Donegal Group Incorporation provides personal and commercial lines of property and casualty insurance to businesses and individuals in the Mid-Atlantic, Midwestern, New England, and southern states. The company beat estimates in the trailing four quarters by 248.34%, on average.
American Equity Investment Life Holding Company provides life insurance products and services in the United States. The company beat estimates in the trailing four quarters by 47.63%, on average.
Primerica Incorporation provides financial products to middle income households in the United States and Canada. The company beat estimates in the trailing four quarters by 4.10%, on average.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Here's Why You Should Hold on to Voya Financial (VOYA) Now
Voya Financial Incorporation (VOYA - Free Report) is well-poised for growth backed by solid market presence and prudent capital deployment.
Estimates for Voya Financial have been revised upward over the past seven days, reflecting analysts’ confidence in the stock. The Zacks Consensus Estimate for 2020 earnings per share has moved up 0.2% in the said time frame. The company also beat estimates in two of the trailing four quarters by 0.86%, on average.
Shares of Voya Financial have gained 45.3% year to date, outperforming the industry’s rally of 25.9%.
Voya Financial’s core businesses segments Retirement, Investment Management and Employee Benefits are driving the company’s bottom line. These businesses fetch higher return and boast a solid market presence.
The company is committed to its objective of achieving improving EPS on the back of organic growth, cost savings and capital management. For 2019, the company expects normalized EPS growth to be around 10%.
Banking on operational excellence, the company deploys capital effectively to enhance shareholder value. Recently in August 2019, the company hiked dividend by 1400%. These endeavors make the stock an attractive pick for yield-seeking investors.
This Zacks Rank #3 (Hold) life insurer remains focused on reducing expenses. The company anticipates achieving run rate cost savings of at least $250 million by 2020 end.
The Zacks Consensus Estimate for 2019 is pegged at $4.97, indicating an improvement of 23% from the year-ago reported figure. The expected long-term earnings growth rate is pegged at 19.6% which betters the industry average of 11.4%. The stock also carries a favorable Value Score of B.
Stocks to Consider
Some better-ranked stocks from the same space are Donegal Group Incorporation (DGICA - Free Report) , American Equity Investment Life Holding Company (AEL - Free Report) and Primerica Incorporation (PRI - Free Report) . While Donegal Group Incorporation and American Equity Investment sport a Zacks Rank #1 (Strong Buy), Primerica carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Donegal Group Incorporation provides personal and commercial lines of property and casualty insurance to businesses and individuals in the Mid-Atlantic, Midwestern, New England, and southern states. The company beat estimates in the trailing four quarters by 248.34%, on average.
American Equity Investment Life Holding Company provides life insurance products and services in the United States. The company beat estimates in the trailing four quarters by 47.63%, on average.
Primerica Incorporation provides financial products to middle income households in the United States and Canada. The company beat estimates in the trailing four quarters by 4.10%, on average.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>